LCTX

Lineage Cell Therapeutics, Inc.

Small CapHealthcareAMEX
Weak38th percentile vs Healthcare stocks

Updated: Oct 30, 2026, 2:17 AM

Open LCTX on TradingViewAffiliate link
LCTXBELOW 200-DAY

Lineage Cell Therapeutics, Inc.

$1.03
-22.5% vs 200-day

Position vs 200-day MA

-22.5% below 200-day MA

LCTX has traded below its 200-day MA for 128 days and ranks at the 38th percentile of Healthcare stocks. This is broad underperformance, not just a pullback.

Price

$1.03

200-day MA

$1.33

Streak below

128 days

Avg volume (90d)

1.4M

Market cap

$263M

Participation around LCTX

Above 200-day MA

LCTX's trend and the participation around it are sending mixed signals.

Healthcare

36%

310 of 855 stocks

S&P 500

63%

316 of 498 stocks

This stock is currently below its 200-day average. The comparison shows how much support the move has around it.